You are currently viewing a new version of our website. To view the old version click .

Innovative Applications and Therapeutic Potential of Cannabinoids

This special issue belongs to the section “Medicinal Chemistry“.

Special Issue Information

Dear Colleagues,

The Special Issue on “Innovative Applications and Therapeutic Potential of Cannabinoids” explores the diverse uses of cannabinoids in modern medicine and therapeutics. In recent years, there has been growing interest in cannabis and cannabinoids due to their potential therapeutic benefits. Our knowledge about secondary cannabis metabolites, including cannabinoids, terpenes, and other constituents, is growing. The mechanisms underlying their biological activity involve interactions with the endocannabinoid system and other molecular targets. These interactions influence various physiological processes, such as pain, mood, and inflammation. Continued research is crucial to fully elucidate these mechanisms and optimize the therapeutic use of cannabis.

In this Special Issue, we aim to gather articles that explore the latest advances and emerging trends in the applications of cannabis and cannabinoids. We welcome submissions that focus on a broad range of topics, including innovative therapeutic uses, novel formulations, and targeted delivery systems. Our goal is to highlight cutting-edge research and developments that showcase the therapeutic potential and diverse applications of cannabis and cannabinoids. This Special Issue collates studies and articles highlighting the significant progress made in understanding the pharmacological properties of cannabis and its constituents, their mechanisms of activity, and their potential benefits in treating various medical conditions.

Dr. Anna Stasiłowicz-Krzemień
Prof. Dr. Judyta Cielecka-Piontek
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cannabis
  • cannabinoids
  • cannabidiol
  • tetrahydrocannabinol
  • endocannabinoid system
  • biopharmaceuticals
  • pharmacology
  • drug delivery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247